| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/06/2022 | Quince Therapeutics, Inc. | CRTX | Payment of Exercise | Common Stock | 10.9k | $2.86 | $31.2k | | 06/06/2022 |
| 03/03/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Common Stock | 155.5k | $0.00 | $0 | | 03/03/2022 |
| 01/03/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Stock option (right to buy) | 125k | $13.39 | $1.7M | | 01/03/2022 |
| 12/14/2020 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (Right to Buy) | 40k | $0.27 | $10.8k | | 12/11/2020 |
| 12/14/2020 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 900 | $32.59 | $29.3k | | 12/11/2020 |
| 12/14/2020 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 400 | $32.59 | $13k | | 12/11/2020 |
| 12/14/2020 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 9.5k | $31.79 | $302.8k | | 12/11/2020 |
| 12/14/2020 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 13.2k | $30.91 | $408k | | 12/11/2020 |
| 12/14/2020 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 14.3k | $30.15 | $430.4k | | 12/11/2020 |
| 12/14/2020 | Quince Therapeutics, Inc. | CRTX | Sale | Common Stock | 1.7k | $28.80 | $49k | | 12/11/2020 |
| 12/11/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 100k | $29.60 | $3M | | 12/11/2020 |
| 12/10/2020 | Quince Therapeutics, Inc. | CRTX | Exercise | Stock Option (Right to Buy) | 3.5k | $0.27 | $945 | | 12/10/2020 |
| 05/14/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 30k | $45.88 | $1.4M | | 05/14/2020 |
| 02/06/2020 | Quince Therapeutics, Inc. | CRTX | Grant | Stock Option (Right to Buy) | 100k | $54.85 | $5.5M | | 02/06/2020 |